Specific gut bacteria species (R inulinivorans) linked to muscle strength

Converts muscle fibres to ‘fast-twitch’ (type II), designed for short intensive movement Holds promise as nutraceutical for treating age-related muscle wasting, say researchers A species of gut bacteria called Roseburia inulinivorans is specifically associated with human muscle strength and improved muscular performance in mice, finds research published online in the journal Gut.  R ...

2026-03-11T10:07:44+00:0011 March 2026|Gut, Press release|

7 hours 18 mins may be optimal sleep length for avoiding type 2 diabetes precursor

Weekend catch-ups linked to heightened risk of insulin resistance in those sleeping more Sleeping for 7 hours and 18 minutes every night may be the sweet spot for warding off the risk of insulin resistance—the precursor to type 2 diabetes—suggests a large observational study published in the open access journal BMJ ...

2026-03-05T11:20:57+00:004 March 2026|BMJ Open Diabetes Research and Care, Press release|

Pollen exposure linked to poorer exam results taken at the end of secondary school

Effects strongest for subjects involving maths, including physics and chemistry Recognition needed of this and its potential impact on future prospects, say researchers Pollen exposure is linked to poorer exam results taken at the end of secondary (high) school (matriculation), with the effects especially noticeable in subjects involving maths, including ...

Stimulating international research dialogue on SGLT2 inhibitors and immune risk

The BMJ research: sodium-glucose cotransporter-2 inhibitors and risk of autoimmune rheumatic diseases In October 2025, The BMJ published the first nationwide population based cohort study to examine the association between sodium-glucose cotransporter-2 (SGLT2) inhibitors and risk of autoimmune rheumatic diseases (ARDs). Drawing on data from more than ...

2026-04-09T13:31:11+01:0027 February 2026|Corporate announcement, Our impact, The BMJ|

Many post-authorisation studies fail to comply with public disclosure rules 

Better adherence is required for greater research transparency, say researchers  Many post-authorisation studies registered with the European Medicines Agency (EMA) fail to comply with legal requirements and recommendations to make their findings public, finds a study published by The BMJ today. Post-authorisation studies (PAS) are carried out after a medicine is approved ...

2026-02-25T17:43:55+00:0026 February 2026|Press release, The BMJ|
Go to Top